Systems and methods for treating obesity

Information

  • Patent Grant
  • 7753870
  • Patent Number
    7,753,870
  • Date Filed
    Friday, March 25, 2005
    19 years ago
  • Date Issued
    Tuesday, July 13, 2010
    13 years ago
Abstract
Methods and devices for simulating a gastric bypass and reducing the volume of the stomach involve placing a tubular liner along the lesser curve of the stomach cavity. Also, methods and devices for slowing gastric emptying involve placing valves within the stomach cavity near the gastro-intestinal junction and/or the pylorus. These methods and devices may prevent a patient from drinking and eating large volumes at one time and from eating slowly all day.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention pertains to medical equipment and more particularly to mechanical methods for reducing the volume of the stomach for the treatment of obesity.


2. General Background and State of the Art


Approximately 64% of Americans are overweight and obesity is rapidly becoming an epidemic resulting in a multitude of co-morbidities (e.g. cardiovascular disease, diabetes, etc.) and enormous medical costs. Approximately $75 billion dollars are spent each year on weight-related diseases in the US alone.


Historically, methods of weight reduction have ranged from oral pharmacological means, a multitude of diets, and various exercise programs. These approaches have generally resulted in temporary weight loss, with no or limited long-term benefit.


In recent years, the concept of obesity being a disease has gained momentum. To that end, surgical treatments have been developed to provide a more permanent solution (e.g. stomach stapling, gastric bypass, and the like). However, these treatments are generally surgical in nature, which imply inherent risk and high cost to the patient.


Thus, it remains desirable to develop new alternatives to provide non-invasive or minimally-invasive solutions to obesity.


SUMMARY OF THE INVENTION

The standard gastric bypass procedure provides not only a restrictive element (i.e., a small pouch to reduce food intake) but also allows food to bypass the majority of the stomach. This feature may result in improved weight loss for several reasons. One reason may be that the food never enters the stomach and thus, the production of the hormone ghrelin (produced in the fundus of the stomach) is reduced. Ghrelin stimulates appetite and fat accumulation, and therefore, a reduction in production of ghrelin could contribute to improved weight loss.


The gastric bypass procedure also bypasses a portion of the small intestine, which may lead to some malabsorption of nutrients, contributing to improved weight loss. It has also been shown that slowed gastric emptying may provide additional weight loss. To that end, several methods for slowing gastric emptying are provided.


A method for reducing the volume of the stomach involves inflating a hollow balloon that extends from the upper portion of the stomach down to approximately the duodenum. The balloon may be inflated with air, saline, or compounds which act to stiffen the balloon. In order to maintain a central lumen for food passage, the internal lumen of the balloon may be constructed of a less-compliant material than the outer surface of the balloon which contacts the stomach wall. The outer surface balloon material is designed to expand to contact the stomach wall and seal against it, whereas, the internal portion of the balloon is designed to provide a lumen and sufficient column strength to not longitudinally compress to dislodge the device. The internal lumen of the balloon may also be reinforced with a super-elastic wire form to prevent lumen collapse.


An alternative construction would provide two independently inflated balloons, one of which would seal near the esophageal-stomach junction and one which would seal near the stomach-duodenum junction. The balloons would be mounted on an extrusion with independent inflation lumens and a relatively large central lumen to allow for food passage. The food passage lumen may be fenestrated to allow for gastric juices to enter the food channel. The extrusion is sufficiently stiff to prevent radial or longitudinal collapse and the balloons aid in sealing against the stomach wall and further prevent migration. In yet another embodiment, this device is constructed such that a member attached to the distal balloon moves independently from the member attached to the proximal balloon in a telescoping manner to allow for length adjustment.


The above-mentioned balloon configurations may also incorporate proximal and/or distal stents or stent-grafts, which act to further mitigate the risk of migration of the device.


Another method for reducing stomach volume involves placing a valve structure into the stomach. Various valve structures may be utilized and act to limit the flow of ingested food into the stomach, resulting in feelings of satiety more quickly. One configuration may be a band with spokes that point towards the center of the band, but are not connected. These spokes are sufficiently resilient to only flex open to allow large amounts of food to pass. As the patient eats, food builds up on the spokes, until the weight is great enough to deflect said spokes, allowing the food to pass more readily. The band is attached to the stomach via various means, including staples, rivets, suture, adhesive or the like. The device may be constructed out of various resilient materials, including shape-memory alloys, stainless steel, Elgiloy, various polymers, or composites. Additionally, an optional band of fabric or mesh may be incorporated into the device to aid in attachment. Yet alternatively, a stent may be incorporated into the device to hold the device in position without the need for mechanical fixation, but may also be reinforced with said mechanical means.


An alternative configuration involves a valve structure consisting of a ring connected to a fabric or mesh substrate. The substrate may be constructed from polyester, PTFE, or the like. It is slitted to create at least one flap, and the flap(s) are constrained by a super-elastic wire form, which is sufficiently resilient to limit the flow of ingested food into the stomach. The wire form may be constructed from super-elastic materials, stainless steel, Elgiloy, or the like. Optionally, the wire form is also connected to the ring to provide additional stiffness. The ring may be constructed from various metals or polymers and incorporates anchoring points for attaching the device to the stomach wall.


Another valve design involves placing a valve similar to a “duckbill” or “double duckbill” configuration. The valves are sufficiently resilient to only flex open to allow large amounts of food to pass. As the patient eats, food builds up in the valve until the weight is great enough to deflect the flaps of the valve, allowing the food to pass more readily. The valve is attached to the stomach via various means, including staples, rivets, suture, adhesive or the like. The device may be constructed out of various resilient materials, including silicone, chronoprene, C-Flex, urethane, polyester fabric/mesh with shape-memory alloys, stainless steel, Elgiloy, various polymers, or composites. Additionally, an optional band of fabric or mesh may be incorporated into the device to aid in attachment. Yet alternatively, a stent may be incorporated into the device to hold the device in position without the need for mechanical fixation, but may also be reinforced with said mechanical means.


Another valve embodiment involves placing a slitted diaphragm in the stomach. The diaphragm has at least one slit, and may be constructed of pliable materials such as silicone, chronoprene, C-Flex, urethane, or other such materials. The diaphragm is sufficiently resilient to only flex open to allow large amounts of food to pass. As the patient eats, food builds up on the diaphragm until the weight is great enough to deflect the flaps of the valve, allowing the food to pass more readily. The valve is attached to the stomach via various means, including staples, rivets, suture, adhesive or the like. The device may be constructed out of various resilient materials, including silicone, polyester fabric/mesh with shape-memory alloys, stainless steel, Elgiloy, various polymers, or composites. Additionally, an optional band of fabric or mesh may be incorporated into the device to aid in attachment. Yet alternatively, a stent may be incorporated into the device to hold the device in position without the need for mechanical fixation, but may also be reinforced with the mechanical means.


A method for isolating food from the fundus is to provide a tube which bypasses food through the stomach without allowing it to enter the stomach itself. The tube could be constructed from reinforced PTFE or polyester (PET) and may optionally be fenestrated to allow for gastric juices to enter the remainder of the digestive tract.


There are also mechanical methods for slowing gastric emptying. A variety of pressure relief valves can be imagined, which are placed in the antrum of the stomach before the pyloric valve. The valves are designed to hold more pressure than the pyloric valve and only open when a minimum pressure is applied. Types of valves include, but are not limited to the previously-described duck-bill, double duck-bill, slitted diaphragm, and the like. Another valve type includes the flapper valve. These valves may be used in conjunction with the other elements of the present invention, including a restrictive element near the gastro-intestinal junction and an isolation element, such at a tube extending from the restrictive element to the pressure relief valve.


Finally, one of the major drawbacks of purely restrictive procedures is that the restriction does not adequately restrict fluid intake or provide a solution for individuals who eat (i.e., graze) small portions throughout the day. To mitigate this limitation, a combination device consisting of both a restrictive element and an element similar to those described as pressure relief valves throughout, may provide a solution. The device would be placed near the gastro-intestinal junction, provide an adjustable restriction to food intake, and provide a means to prevent continuous fluid consumption (e.g., shakes) and continuous food intake.


In yet another embodiment, a liner may be attached within the stomach cavity near the gastroesophageal junction (“GEJ”). An inlet end of the liner will be secured to the stomach wall by stapling the liner within a single or dual fold of the stomach wall around the circumference of the inlet end. The liner will also be secured along the lesser curve of the stomach, by placing plications to secure the liner within single or dual folds. The liner may extend along the lesser curve to the pylorous, or any length in between the GEJ and the pylorous.


It can be appreciated that all of the elements described herein may be configured in a multitude of combinations to achieve desired weight loss.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 depicts a schematic view of a hollow balloon liner inflated in the stomach cavity.



FIG. 2 depicts a schematic view of a balloon device having a tube connected between a first balloon inflated near the gastrointestinal junction and a second balloon inflated near the pylorus.



FIG. 3 depicts another embodiment of the balloon device shown in FIG. 2 including a first stent connected to the first balloon and a second stent connected to the second balloon.



FIG. 4 depicts a top planar view of a valve.



FIG. 5 depicts a perspective view of the valve in FIG. 4.



FIG. 6 depicts a schematic view of the valve shown in FIG. 4 positioned near the gastrointestinal junction.



FIG. 7 depicts a planar view of another embodiment of a valve.



FIG. 8 depicts a cross-sectional view of a duckbill valve.



FIG. 9 depicts a cross-sectional view of a double duckbill valve.



FIG. 10 depicts a schematic view of the duckbill valve of FIG. 8 positioned near the gastrointestinal junction.



FIG. 11 depicts a perspective view of a slitted diaphragm valve.



FIG. 12 depicts a perspective view of another embodiment of the slitted diaphragm valve of FIG. 11 including a fabric/mesh band.



FIG. 13 depicts a perspective view of another embodiment of the slitted diaphragm valve of FIG. 11 including a stent.



FIG. 14 depicts a top planar view of a flapper valve.



FIG. 15 depicts a side elevational view of the flapper valve shown in FIG. 14 in an open configuration.



FIG. 16 depicts a schematic view of a pressure relief valve disposed near the pylorus.



FIG. 17 depicts a schematic view of a pressure relief valve disposed near the pylorus and a restrictive valve disposed near the gastrointestinal junction.



FIG. 18 depicts a schematic view of an isolation element or liner connected between the pressure relief valve and restrictive valve of FIG. 17.



FIG. 19 depicts another embodiment of a gastric device.



FIG. 20 depicts a perspective view of a stoma device.



FIG. 21 depicts a top planar view of the stoma device shown in FIG. 20.



FIG. 22 depicts a schematic view of another embodiment of a gastric device attached to the lesser curve of the stomach cavity.



FIG. 23 depicts a schematic view of yet another embodiment of a gastric device attached to the lesser curve of the stomach cavity.



FIG. 24 depicts a perspective view of an adjustable gastric device.



FIG. 25 depicts a perspective view of the adjustable gastric device of FIG. 24 with a suture tensioned to form a reduced stoma.



FIG. 26 depicts a schematic view of the adjustable gastric device of FIG. 25 attached in the stomach cavity near the gastrointestinal junction.



FIG. 27 depicts a perspective view of another embodiment of an adjustable gastric system including a spine.



FIG. 28 depicts a perspective view of the adjustable gastric system of FIG. 27 with a suture tensioned to form a reduced stoma.



FIG. 29 depicts a schematic view of the adjustable gastric device of FIG. 28 attached in the stomach cavity near the gastrointestinal junction.



FIG. 30 depicts a perspective view of another embodiment of an adjustable gastric system including a spine and a spring element.



FIG. 31 depicts a perspective view of another embodiment of an adjustable gastric system including a docking station.



FIG. 32 depicts a perspective view of another embodiment of the adjustable gastric system of FIG. 31 including a spine for attachment to the lesser curve of the stomach cavity.



FIG. 33 depicts a liner being loaded onto a tissue acquisition and fixation device.



FIG. 34 depicts the liner being positioned with the tissue acquisition and fixation device just below the gastroesophageal junction.



FIG. 35 depicts the liner secured near the gastroesophageal junction and along the lesser curve of the stomach with multiple plications.



FIG. 36 depicts a cross-sectional view taken along line 36-36 of the FIG. 35.



FIG. 37 depicts a cross-sectional view taken along line 37-37 of the FIG. 35.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Methods and devices discussed in detail below are used to optimize patient weight loss. One method for simulating a gastric bypass and reducing the volume of the stomach involves placing a liner within the stomach cavity. Also, methods and devices for slowing gastric emptying involve placing valves within the stomach cavity near the gastro-intestinal junction and/or the pylorus. The methods and devices described below may prevent a patient from drinking and eating large volumes at one time and from eating slowly all day.


In one embodiment, a hollow balloon liner 20 is inflated and extended from the upper portion of the stomach, near the gastrointestinal junction down to approximately the duodenum. The inflated hollow balloon liner simulates a gastric bypass and reduces the volume of the stomach cavity. Referring to FIG. 1, the balloon includes a body 22 having a first or input end 24 and a second or output end 26, and a central lumen 28 extends between the first and second end of the balloon body. Also, the body of the balloon has an outer surface 30 and an inner surface 32 which defines the central lumen. In one embodiment, the length of the entire balloon body may be tapered from the first end to the second end. The first end of the balloon may have a larger diameter than the second end of the balloon, so that when inflated, the first end can secure itself near the gastrointestinal junction. At the second end, the diameter does not have to be as large as the first end to secure itself near the duodenum because of the size of the stomach anatomy. The central lumen may include a larger conical shape 34 near the first end of the balloon to help funnel food through the central lumen of the balloon. The remaining portion of the central lumen may have a consistent diameter, or in other embodiments the dimension of the central lumen may vary. In order to maintain a central lumen for food passage, the central lumen of the balloon may be constructed of a less-compliant material than the outer surface of the balloon which contacts the stomach wall. The outer surface balloon material is designed to expand to contact the stomach wall and seal against it, whereas, the internal portion of the balloon is designed to provide a lumen and sufficient column strength to not longitudinally compress to dislodge the device. The internal lumen of the balloon may also be reinforced with a super-elastic wire form to prevent lumen collapse. Balloon elements may be formed of compliant or noncompliant materials, such as thermoplastic elastomers and other materials including nylon, polyester, silicone, polyolefin, latex, cross-linked polyethylene, polyethylene terephthalate (PET), polyurethane and the like.


During the procedure for placing the balloon 20 within the stomach cavity, the balloon is deflated and advanced down the esophagus to the stomach cavity until the second end 26 is located near the duodenum and the first end 24 is positioned near the gastrointestinal junction. The balloon is next inflated using a fluid communication port or a catheter tube 36 that is also delivered down the esophagus and is removably connected to an inflation port 38 located on the body 22 of the balloon. The balloon may be filled with various materials to effect a temporary treatment (i.e., deflate and remove balloon) or a permanent treatment (i.e., a cross-linking material that hardens once balloon is inflated). Air, saline, or compounds which act to stiffen the balloon may be transported through the catheter tube and into the balloon. Once the balloon is inflated and secured against the stomach wall, the catheter is removed from the inflation port, leaving only the balloon which reduced the volume of the stomach.


Another embodiment of a balloon device 40 is shown if FIG. 2. The balloon device includes a first balloon 42 located at a first or input end 44 and a second balloon 46 located at a second or output end 48. A cylindrical body or tube 50 is connected between the first and second balloons, and a central lumen 52 of the tube is in fluid communication with the first end and the second end to allow for food passage. In one embodiment, the balloons are mounted on the tube, so that the tube extends through the balloons. However, in another embodiment, the balloons are attached to the ends of the tube, so that each balloon forms an independent inflation lumen that is in communication with the central lumen of the tube. When inflated, the balloons aid in sealing against the stomach wall and further prevent migration of the balloon device. In yet another embodiment, this device is constructed such that a tubular member attached to the second or distal balloon moves independently from a tubular member attached to the first or proximal balloon in a telescoping manner to allow for length adjustment. The tube and the central lumen are sufficiently stiff to prevent radial or longitudinal collapse of the balloon device, the tube may optionally include fenestrations 54 to allow gastric juices to enter the new digestive tract which includes the central lumen of the balloon device. Similar to the above embodiment, the central lumen may include a larger conical shape near the first end of the balloon to help funnel food through the central lumen of the balloon device. The remaining portion of the central lumen may have a consistent diameter, or in other embodiments the dimension of the central lumen may vary. In order to maintain a central lumen for food passage, the cylindrical body or tube may include PET, Nylon, polyester, PTFE, polyethylene, polystyrene, polyurethane, polyethylene terephthalate. The material of the balloons is designed to expand to contact the stomach wall and seal against it, whereas, the tube of the balloon device is designed to provide a lumen and sufficient column strength to not longitudinally compress to dislodge the device. The central lumen of the tube may also be reinforced with a super-elastic wire to prevent the lumen from collapsing.


During the procedure for placing the balloon device 40 within the stomach cavity, the first and second balloons 42 and 44 are deflated and advanced down the esophagus, along with the tube 50, to the stomach cavity. The first balloon is positioned near the gastro-intestinal junction and the second balloon is positioned near the stomach-duodenum junction. The balloons are next inflated using a fluid communication port or a catheter tube 56 that is also delivered down the esophagus and is removably connected to an inflation port 58 located on the body of the first balloon. In one embodiment, only one inflation port is needed to inflate both the first and the second balloon, where an inflation lumen is disposed on the balloon device and in fluid communication between the first and second balloons. Yet in another embodiment, there may be separate inflations ports for independently inflating each balloon. The balloons may be filled with various materials to effect a temporary treatment (i.e., deflate and remove balloon) or a permanent treatment (i.e., a cross-linking material that hardens once balloon is inflated). Air, saline, or compounds which act to stiffen the balloons may be transported through the catheter tube and into the balloon. Once the balloons are inflated and secured against the stomach wall, the catheter is removed from the inflation port, leaving only the balloons which reduced the volume of the stomach.


Another embodiment of the balloon device 40 is shown in FIG. 3, where optional stents are included to improve fixation of the device and prevent migration within the stomach cavity. In this embodiment a first or proximal stent 60 is attached to the proximal end of the first balloon 42, and a second or distal stent 62 is attached to the distal end of the second balloon 46. The stents may be self expanding or balloon expandable, each of which are known in the art. In operation, the proximal stent 60 may be connected to the liner via a strut or narrowing, so that placement of the proximal stent in the esophagus does not impair the function of the lower espophageal sphincter (LES). By having a low profile strut of narrowing connecting the two, the force of the LES could overcome the structure and not be compromised (i.e. kept open), but the stent and the liner device could remain coupled for purposes of anchoring the prosthesis within the gastric cavity.


Another method for reducing stomach volume involves placing a valve structure into the stomach. As will be described in detail, various valve structures may be utilized and act to limit the flow of ingested food into the stomach, resulting in feelings of satiety more quickly. Referring to FIGS. 4 through 6, one embodiment of a valve 70 includes a band or circular body 72 having an outer surface 74 and an inner surface 76. The valve also include a plurality of restriction members or spokes 78 that each have an attached end 80 connected to the inner surface of the band and a free end 82 that points towards the center of the band. The free ends of the spokes are not connected together, and may or may not contact one another. In use, the resilient members or spokes are sufficiently resilient to only flex open to allow large amounts of food to pass. As the patient eats, food builds up on the spokes, until the weight is great enough to deflect the spokes, as shown in FIG. 5, allowing the food to pass more readily. As best shown in FIG. 4, the spokes are depicted in a wire-form configuration, but could be tubes, ribbon, cable, braid, or other geometry. Additionally, the spokes may be straight as shown, or they may have a shape set into them.


The valve 70 may be attached to the stomach wall via various means, including anchors, staples, rivets, suture, adhesive or the like, such as those disclose in U.S. Ser. Nos. 11/056,327 and 11/067,598, the entire contents of each are incorporated herein by reference. In one embodiment, an optional band of fabric or mesh may be incorporated into the valve device to aid in attachment, whereby the anchors or staples would be placed through the fabric or mesh bands and into the stomach wall. Yet in another embodiment, a stent may be incorporated into the valve device to hold the valve device in position without the need for mechanical fixation, but may also be reinforced with mechanical means. The valve may be anywhere along the length of the stomach cavity, however, it is preferred that the valve be positioned near the gastrointestinal junction, as shown in FIG. 6, so that the valve restricts incoming food. The band 72 and the spokes 78 of the valve may be constructed out of various resilient materials, including shape-memory alloys, stainless steel, Elgiloy, various polymers, or composites.


Another embodiment of the valve device 70 is shown in FIG. 7. Instead of spokes being connected to the inner surface of the band 72, a fabric or mesh substrate 84 is attached to the inner surface of the band or ring. The fabric/mesh substrate may be constructed from polyester, PTFE, or the like. In one embodiment, the fabric mesh substrate includes at least one slit 86 to create at least two flaps 88. FIG. 7 shows the fabric/mesh substrate to include two slits and four flaps. The flaps may be constrained by a wire form 90, which is sufficiently resilient to limit the flow of ingested food into the stomach. The wire form may be constructed from super-elastic materials, such as nitinol, stainless steel, Elgiloy, or the like. Optionally, the wire form may be connected to the band or ring to provide additional stiffness. The band or ring may be constructed from various metals or polymers and incorporates anchoring points for attaching the device to the stomach wall.


Another valve embodiment is shown in FIGS. 8 through 10 and involves placing a valve similar to a “duckbill” or “double duckbill” configuration within the stomach cavity near the esophagus/stomach junction. The duckbill valve 100 includes an upper circular portion 102 that defines an inlet 104, and eyelets or attachment points 106 disposed on the upper circular portion for attaching the valve to the stomach wall. In one embodiment as shown in FIG. 8, the duckbill valve includes a central portion 108 that is cylindrical and a distal tapered portion or flaps 110 that taper downward to form an outlet 112 that is smaller in diameter than the inlet.


In another embodiment as shown in FIG. 9, a double duckbill valve 114 includes an upper circular portion 116 that defines an inlet 118, and eyelets or attachment points 120 disposed on the upper circular portion for attaching the valve to the stomach wall. In one embodiment, the double duckbill valve includes a distal tapered portion or flaps 122 that taper downward to form a first outlet 124 and a second outlet 126. The combined diameter of the first and second outlets is smaller than the diameter of the inlet. In another embodiment, the double duckbill valve may also include a central cylindrical portion disposed between the upper circular portion and the distal tapered portion.


The duckbill valve 100 or the double duckbill valve 114 is to be delivered to the stomach cavity and positioned near the gastrointestinal junction as shown in FIG. 10. Both of the valves 100 and 114 are sufficiently resilient to only flex open to allow large amounts of food to pass. As the patient eats, food builds up in the valve until the weight is great enough to deflect the flaps of the valve, allowing the food to pass more readily. The valve 100 or 114 is attached to the stomach via various means, including anchors, staples, rivets, suture, adhesive or the like that are secured through the eyelets 106 or 120 and into the stomach wall. The duckbill or double duckbill valve may be constructed out of various resilient materials, including silicone, chronoprene, C-Flex, urethane, polyester fabric/mesh with shape-memory alloys, stainless steel, Elgiloy, various polymers, or composites. Additionally, an optional band of fabric or mesh may be incorporated into the device to aid in attachment. Yet alternatively, a stent may be incorporated into the device to hold the device in position without the need for mechanical fixation, but may also be reinforced with the mechanical means.


Another valve embodiment is shown in FIGS. 11 through 13. FIG. 11 depicts slitted diaphragm valve 130 that includes a cylindrical body 132 having an outer surface 134 and an inner surface 136. The cylindrical body also has a first end 138 defining an inlet 140 and a second end 142 defining an outlet 144. Eyelets or attachment points 146 are disposed at the first end of the cylindrical body and are used to help secure the valve to the stomach wall. A diaphragm 148 is attached to the inner surface of the cylindrical body and includes at least one slit 150 forming at least two flaps 152. As shown in FIG. 11, one embodiment includes a diaphragm with two slits forming four flaps. The diaphragm may be constructed of pliable materials such as silicone, chronoprene, C-Flex, urethane, or other such materials. Also, the diaphragm is sufficiently resilient to only flex open to allow large amounts of food to pass. As the patient eats, food builds up on the diaphragm until the weight is great enough to deflect the flaps of the valve, allowing the food to pass more readily. The valve is attached to the stomach near the gastrointestinal junction via various means, including anchors, staples, rivets, suture, adhesive or the like, that are secured through the eyelets and into the stomach wall. The cylindrical body may be constructed out of various resilient materials, including silicone, polyester fabric/mesh with shape-memory alloys, stainless steel, Elgiloy, various polymers, or composites.


In other embodiment as shown in FIG. 12, an optional band of fabric or mesh 154 may be disposed on the first end 138 of the cylindrical body 132 to aid in attachment. The fabric/mesh band may be constructed from polyester or the like. Once the valve 130 is positioned within the stomach, anchors, staples, rivets, sutures, or adhesives could then be positioned through the fabric/mesh band into the stomach wall to secure the valve.


In another embodiment as shown in FIG. 13, a stent 156 may be disposed on the first end 138 of the cylindrical body of the valve 130 to hold the valve in position without the need for mechanical fixation. The stent may be a self-expanding stent or a balloon-expandable stent, both or which are known in the art. Once the valve is positioned within the stomach cavity, the stent may be expanded provide a frictional fixation to the esophagus and/or upper portion of the stomach. In addition, other mechanical means, such as the use of anchors, staples, rivets, sutures, or adhesives, may also be used in conjunction with the stent to secure the valve. In another embodiment, the stent may also be covered in the fabric or mesh described in FIG. 12 to facilitate attachment to the stomach wall.


Yet another embodiment of a valve is shown in FIGS. 14 and 15. A flapper valve 160 includes a cylindrical body 162 having a first end 164 defining a inlet 166 and a second end 168 defining an outlet 170. A flap 172 is disposed near the first end of the cylindrical body and attached at a connection point 174 to the cylindrical body, leaving a small gap or space 176 between the flap and the cylindrical body. Eyelets or attachment points 178 are disposed at the first end of the cylindrical body to aid in attaching the flapper valve to the stomach wall. In a closed configuration as shown in FIG. 14, the flap blocks the inlet of the valve. The connection between the flap and the cylindrical body is sufficiently resilient to only flex open to allow large amounts of food to pass. As the patient eats, food builds up on the flap until the weight is great enough to deflect the flap of the valve to an open configuration, as shown in FIG. 15, allowing the food to pass more readily. The flapper valve may be attached to the stomach near the gastrointestinal junction via various means, including anchors, staples, rivets, suture, adhesive or the like, that are secured through the eyelets and into the stomach wall. The cylindrical body and flap may be constructed out of various resilient materials, including silicone, polyester fabric/mesh with shape-memory alloys, stainless steel, Elgiloy, various polymers, or composites.


In one embodiment of a method for slowing gastric emptying, a variety of pressure relief valves 190 can be placed in the antrum of the stomach before the pyloric valve as shown in FIG. 16. The pressure relief valve may be any of the valves previously discussed, including the valve 70, the duckbill or double duckbill valve 100 or 114, the slitted diaphragm valve 130, or the flapper valve 160. The pressure relief valve are designed to hold more pressure than the pyloric valve, and will only open when a minimum pressure is applied.


In another embodiment of a method for slowing gastric emptying, the pressure relief valve 190 may be used in conjunction with a restrictive valve or device 192 placed near the gastro-intestinal junction as shown in FIG. 17. The restrictive valve or device 192 may be any of the valves previously discussed, including the valve 70, the duckbill or double duckbill valve 100 or 114, the slitted diaphragm valve 130, or the flapper valve 160. The pressure relief valve and the restrictive valve may be identical valves or they may be different valves depending on the embodiment. The restrictive valve builds food up at the valve until the weight is great enough to open the valve and allow food to pass more readily.


In yet another embodiment of a method for slowing gastric emptying, an isolation element 194, such as a reinforced PTFE or PET graft, is connected between the pressure relief valve 190 and restrictive valve 192 as shown in FIG. 18. The isolation element includes a lumen that is in fluid communication with the outlet of the restrictive valve and the inlet of the pressure relief valve. In one embodiment the isolation element is attached to the lesser curve LC of the stomach with attachment devices 196, such as anchors, staples, rivets, sutures, adhesives, or the like. As a patient eats, food will travel through the restrictive valve and into the isolation element, where it will stay until enough pressure opens the pressure relief valve. It would be possible to place fenestrations within the isolation element to allow gastric juices to flow into the lumen of the isolation element.


Another embodiment of a method and device for slowing gastric emptying is shown in FIGS. 19 through 21. FIG. 19 is a schematic of a gastric device 200 which demonstrates the ability to adjust the stoma size for the restriction of food intake. The device includes a docking station 202, in which various stomas sized matingly engage. The docking station has a cylindrical body 204 with a first end 206 and a second end 208, and at least one slot 209 disposed along the cylindrical body. As shown in FIG. 19, the slot is L-shaped and extends through the first end of the cylindrical body. In one embodiment, there are two slots opposite each other on the cylindrical body. The cylindrical body of the docking station has a diameter that allows for a stoma device 210 to be docked within the docking station.



FIGS. 20 and 21 depict the stoma device having a donut shape. The stoma device includes a cylindrical body 212 having a wall 214 with a thickness that determines the size of a stoma or through hole 216 formed in the center of the cylindrical body. It is preferred that the diameter of the stoma 216 range between about 5 mm and about 20 mm, although the diameter of the stoma may be smaller than 5 mm and larger than 20 mm. An inlet 218 is defined at a first end 220 of the stoma device and an outlet 222 is defined at a second end 224 of the stoma device. In one embodiment, the stoma or through hole may be tapered from the inlet to the outlet to encourage food to travel downward. Also, tabs or lips 225 are formed opposite one another on the outer surface of the stoma device, which engage with the slots 206 of the docking station. In other embodiments, the stoma device may be secured to the docking station 202 with threads, magnetic force, clips, or other mechanical locking means. In use, a physician may easily replace one stoma device for another having a different sized stoma or through hole. For example, if the patient is not losing sufficient weight, a stoma device with a smaller stoma or through hole may be placed within the docking station. Conversely, if the patient is losing too much weight, or if the patient is vomiting excessively, a stoma device with a larger stoma or through hole may be placed within the docking station. It can be appreciated that this docking station may be compatible with many of the valve devices described above. Also, the stoma device may be the restrictive valve or device described in other embodiments above.


Referring again to FIG. 19, the gastric device 200 may also include a food tube or isolation element 226, such as a reinforced PTFE or PET graft, with a first end 228 and a second end 230. The first end is attached to the second end 208 of the docking station 202, and the second end may be connected to a pressure relief valve 190, which has already been described. In one embodiment, the gastric device does not include the pressure relief valve, and the second end is positioned to be in communication with the pylorus. Fenestrations 232 may be disposed along the food tube to allow gastric juices to enter a lumen of the food tube. In one embodiment the food tube or isolation element may be attached to the lesser curve LC of the stomach with attachment devices 196, such as anchors, staples, rivets, sutures, adhesives, or the like. Additionally a funnel 234 may be disposed on the first end 206 of the docking station to encourage food to flow downward to the stoma device 210.


Another embodiment of a gastric device 240 and method for slowing gastric emptying is shown in FIG. 22. The device includes a pressure relief valve 190 and a restrictive valve 192, both of which have already been described. In this embodiment, a spine 242 has a first end 244 attached to the restrictive valve and a second end 246 attached to the pressure relief valve. The spine includes clips 248 attached along the length of the spine which may be crimped into the stomach wall during placement. The device 240 is situated within the stomach cavity so that the spine is secured along the lesser curve LC or the stomach. The spine provides column strength to the device, allowing for fewer attachment points near the gastro-intestinal junction. It also provides additional attachment points, which act to reduce the amount of stress on any one attachment point, thus leading to a more durable attachment. The pressure relief valve may be incorporated to slow gastric emptying, and in another embodiment may not be included in the gastric device. Alternatively, the spine may be attached to the lesser curve via clips, sutures, or the like, and not be pre-attached to the spine. Alternatively, the length of the spine may be adjustable to allow for various patient geometries. One method for adjusting the length of the spine is to employ a telescoping mechanism. Still in another embodiment, a fabric/mesh band may be attached to the spine, allowing for sutures or staples to more easily attach the spine to the lesser curve.


In another embodiment shown in FIG. 23, a gastric device 250 is shown which includes a spring-loaded restrictive element 252, which provides constant pressure at the gastro-intestinal junction. The constant pressure from the spring-loaded restrictive element provides a seal at the gastro-intestinal junction, so that food must enter through the restrictive element, rather than go around it. The spring-loaded restrictive element includes a sealing gasket 254 having a stoma 255 of a desired size, that is positioned on a spring element 256, to continually push the sealing gasket upward or proximally toward the esophagus. The spring element is implanted such that it is normally under compression to provide the upward force necessary to maintain a seal around the gastro-intestinal junction. In one embodiment, the spring element may take the form of a supported fabric structure (i.e., wire covered with PTFE or PET fabric) or may take the form of a bellows, or the like. The spring-loaded restrictive element also includes a docking station 258, which allows for adjustment of the size of the stoma, similar to the docking station 202 described above. Interchangeable sealing gaskets may be used to selectively change the stoma size. It should be noted that the docking station may be incorporated into the spring element or the sealing gasket. The gastric device 250 of this embodiment also includes a spine 260 attached at one end to the docking station, and the spine is used to attach the device along the lesser curve LC of the stomach. Attachment points or clips 262 may be incorporated into the spine or be placed separately around the spine, so as to attach the spine to the lesser curve. Optionally, the spine length may be adjustable to account for various patient geometries. A pressure relief valve 190 may also be included into the gastric device and attached to one end of the spine. As previously described, the pressure relief valve is designed to slow gastric emptying. The valve is designed such that the pressure required to open it is greater than the pressure required to open the pyloric valve. In one embodiment the sealing gasket and the pressure relief valve are expandable members that ratchet open upon an applied internal force (e.g., a balloon). Alternatively, the sealing gasket and the pressure relief valve are self-expanding.


Yet another embodiment of an adjustable gastric system 270 is shown in FIGS. 24 through 26, which may prevent a patient from drinking large volumes and from eating slowly all day. The adjustable gastric system includes fabric or mesh cylindrical body 272 having an inlet 274 at a first end 276 and an outlet 278 at a second end 280. Attachment points or eyelets 281 are disposed at or near the first end of the cylindrical body for passing staples, anchors, or sutures there through to attach the system to the stomach wall near the gastro-intestinal junction. A tensioning member or suture 282 is attached to the cylindrical body in a purse-string fashion between the first and second ends. The suture includes two free ends 284 that are joined with a mechanically adjustable clip 285. A pressure relief valve 286 is attached at the second end of the body blocking the outlet. The pressure relief valve is similar to the pressure relief valve 190 described above, and may be the valve 70, the duckbill or double duckbill valve 100 or 114, the slitted diaphragm valve 130, or the flapper valve 160. Once the gastric system is secured to the stomach wall, the free ends of the suture may be pulled or tensioned to reduce the inner diameter of the cylindrical body, forming a stoma 288 as shown in FIG. 25. The adjustable clip is used to secure the free ends of the suture in position to maintain the desired size of the stoma. At any time the stoma may be adjusted by loosening the clip and either tensioning the suture to further decrease the size of the stoma, or releasing tension of the suture to increase the size of the stoma. The pressure relief valve is such that water may pass freely, but higher-viscosity fluids, such as shakes, can not pass freely. Thus, as the patient drinks a shake, it passes through the stoma but not through the pressure relief valve. The adjustable gastric system will subsequently start to fill up with the shake until it backs up through the stoma and into a pouch 290 that is created above the purse-string suture as shown in FIGS. 25 and 26. The pressure relief valve can be designed to open or partially open at any given pressure, but it is likely that it will open at a pressure that allows the device to back-fill up to or slightly above the first end of the cylindrical body. This same system applies to patients eating slowly throughout the day.


Referring now to FIGS. 27 through 29, another embodiment of the adjustable gastric system 270 is shown including a spine 292 that is connected to the fabric/mesh cylindrical body 272 at the first end 276 and at the second end 280. The spine includes attachment clips 294 that are shown in an open configuration in FIG. 27. During placement of the system within the stomach cavity, the spine allows for attachment of the gastric system to the lesser curve LC of the stomach. Once in position along the lesser curve, the attachment clips are crimped into a closed configuration as best shown in FIG. 28 to secure the spine to the lesser curve. The spine provides column strength, holds the system in place to prevent twisting and/or kinking, and provides additional attachment points to facilitate a more durable implantation.


Another embodiment of the adjustable gastric system 270 is shown in FIG. 30. In this embodiment, a spring element 296 is attached to the fabric/mesh cylindrical body 272 above the purse-string suture 282. Spring element 296 may be formed of multiple coiled wires or wires that are folded in a “zig-zag” pattern along their length, and secured to the valve body at the mouth of the valve, and at least one other portion of the valve spaced longitudinally from the mouth of the valve. The spring elements may be formed of a biocompatible resilient material, such as stainless steel, Elgiloy, NiTi, or a more flexible and conforming material such as silicone, chronoprene, C-Flex, or urethane. This spring-loaded system is implanted in a compressed configuration to apply upward pressure at the gastro-intestinal junction for purposes of an improved seal. The seal caused by the spring element ensures that food enters the inlet 274 of the system, rather than going around the inlet and may also reduce the number of attachment points required at the gastro-intestinal junction.


Another embodiment of an adjustable gastric system 300 is shown in FIG. 31. This system 300 includes fabric or mesh cylindrical body 302 having an inlet 304 at a first end 306 and an outlet 308 at a second end 310. Attachment points or eyelets 311 are disposed at or near the first end of the cylindrical body for passing staples, anchors, or sutures there through to attach the system to the stomach wall near the gastro-intestinal junction. A docking station 312, similar to the docking station 202 described above, is attached to the cylindrical body between the first and second ends, and allows for interchangeable stoma devices 314, similar to the stoma device 210 described above, to be placed. The stoma device includes a stoma 315 that may have a constant diameter or a tapered configuration to encourage food downward and into the device. A pressure relief valve 316 is attached at the second end of the body blocking the outlet. The pressure relief valve is similar to the pressure relief valve 190 described above, and may be the valve 70, the duckbill or double duckbill valve 100 or 114, the slitted diaphragm valve 130, or the flapper valve 160. The pressure relief valve can be designed to open or partially open at any given pressure, but it is likely that it will open at a pressure that allows the device to back-fill up to or slightly above the first end of the cylindrical body.



FIG. 32 shows another embodiment of the adjustable gastric system 300 shown in FIG. 31, including a spine 318 that is connected to the fabric/mesh cylindrical body 302 at least to the first end 306 and at the second end 310. The spine includes attachment clips 320 that are shown in an open configuration in FIG. 32. During placement of the system within the stomach cavity, the spine allows for attachment of the gastric system to the lesser curve LC of the stomach. Once in position along the lesser curve, the attachment clips are crimped into a closed configuration to secure the spine to the lesser curve. The spine provides column strength, holds the system in place to prevent twisting and/or kinking, and provides additional attachment points to facilitate a more durable implantation.


In certain embodiments, fixation devices could be used to secure the valves (70, 100, 114, 130, 160, 190 and 192), tube (50) and isolation elements (194 and 226), spines (242, 260, 292 and 318), and adjustable gastric systems (270 and 300) along the stomach wall. For instance, the system shown having a folder assembly and a fixation assembly as disclosed in U.S. Ser. No. 10/773,883 (“the '883 application”), titled “Single Fold System For Tissue Approximation And Fixation,” could be adopted to secure the above-listed devices along the stomach wall. The '883 application is hereby incorporated by reference in its entirety. The system disclosed in the '883 application is used to create single fold plications within the stomach cavity by acquiring a fold of tissue and then deploying multiple staples sequentially or simultaneously in an organized fashion. Another device that could also be used to secure the above-listed devices along the stomach wall is disclosed in U.S. Ser. No. 10/797,439 (“the '439 application”), titled “Devices And Methods For Placement Of Partitions Within A Hollow Body Organ.” The '439 application is hereby incorporated by reference in its entirety. The tissue acquisition and fixation device disclosed in the '439 application is used to create longitudinal dual fold plications within the stomach wall, by acquiring two folds of tissue and then stapling the folds together.


In use, the device of the '883 application or the '439 application can be altered so that as the fixation device acquires stomach tissue, a portion of the cylindrical body of the valve (70, 100, 114, 130, 160, 190 and 192) would also be acquired by the fixation device. In some embodiments, the valve includes a fabric/mesh band attached to the cylindrical body as shown in FIG. 12, that may be secured within a fold or dual fold of stomach tissue by the device of the '883 application or the '439 application. When attaching the spine (242, 260, 292 and 318) to the lesser curve of the stomach cavity, the device of the '883 application or the '439 application could be altered to acquire the spine along with the fold(s) or stomach tissue along the lesser curve. With the device of the '439 application, the spine could be positioned and secured in between the dual folds. The device of the '883 application or the '439 application could be actuated multiple times to secure the spine along the entire lesser curve of the stomach. The adjustable gastric system (270 and 300) can also be secured to the stomach using the device of the '883 application or the '439 application, by acquiring at least a portion of the fabric/mesh body near the first and/or second ends of the cylindrical body along with the fold(s) of stomach tissue.


Further, other gastric devices from those disclosed above can be attached to the stomach wall using the device of the '883 application or the '439 application. For instance, several embodiments of the “pouch” disclosed in U.S. Pat. No. 6,845,776 can be secured to the stomach wall using either the device of the '883 application or the '439 application. U.S. Pat. No. 6,845,776 is hereby incorporated by reference in its entirety. Also, the “restrictive device” disclosed in PCT/US2004/009269 could be secured to the stomach wall using the device of the '883 application or the '439 application. PCT/US2004/009269 is hereby incorporated by reference in its entirety. One other example includes the “stoma device” or “anchoring ring” disclosed in U.S. Ser. No. 10/698,148, which could also be secured to the stomach wall using the device of the '883 application or the '439 application. U.S. Ser. No. 10/698,148 is hereby incorporated by reference in its entirety.


In another embodiment, the balloon liner 20, balloon device 40, the valves 70, 100, 114, 130, 160, 190 and 192, tube 50 and isolation element 194 and 226, gastric devices 200, 250, 270 and 300, can all be used in combination with local drug delivery to influence satiety and absorption of nutrients. In one embodiment, a “pump and reservoir” and “active agent catheter delivery system,” which are disclosed in U.S. Ser. No. 10/890,340, can be implanted within the patient's body to deliver drugs to the lower gastrointestinal tract while the devices disclosed above can be used to slow gastric emptying or restrict the entrance of food into the stomach cavity.


Another embodiment of a method for placing a liner within the stomach cavity is shown in FIGS. 33 through 37. FIG. 33 shows the tissue acquisition and fixation device 330 having a flexible shaft 332 connected to a handle 334 at one end and a working portion 336 at the other end. A physician can use the handle to steer or control the flexible shaft and actuate the working portion. The working portion includes a cartridge member 338 for holding and dispensing a plurality of staples or anchors, and an anvil member 340. The anvil member is in apposition to the cartridge member and is used to provide a staple closure surface when tissue to be affixed is adequately positioned between the staple cartridge and the anvil. FIG. 33 also shows a liner 342 that is loaded onto the working portion of the tissue acquisition and fixation device to an insertion diameter. A sheath (not shown) may be used to hold the liner at the working portion. The liner may be held against the working portion by any other means, such as by folding and holding the liner between the cartridge member and anvil of the working portion. The liner includes a cylindrical body 344 having an inlet end 346 and an outlet end 348. Depending on the embodiment, the liner may be formed of PET, Nylon, polyester, PTFE, polyethylene, polystyrene, polyurethane, silicone, polyethylene terephthalate, or the like.


Referring now to FIG. 34, once the liner 342 is loaded on the working portion 336 of the tissue acquisition and fixation device 330, the distal end of the device carrying the liner is inserted transorally until the inlet end 346 of the liner is located just below the GEJ. With the liner in the desired position within the stomach cavity, the working portion of the tissue acquisition and fixation device is actuated, as disclosed in the '439 application, to acquire a dual fold of tissue and the body 344 of the liner. In another embodiment, the tissue acquisition and fixation device may acquire a single fold. After acquiring the tissue and the liner, the cartridge member 338 and anvil member 340 are clamped together, and a plurality of staples are ejected into the tissue and the liner, thereby fixing the liner to the stomach wall. The working portion of the tissue acquisition and fixation device is then repositioned at another point around the circumference of the liner near the inlet end, and that point of the liner is then fixed to a single or dual fold of the stomach wall. Multiple plications 350 may be formed around the circumference of the liner near the inlet end of the body to secure the liner to the stomach wall.


Once the proximal end or inlet end 346 of the liner 342 is secured to the stomach wall, the tissue acquisition and fixation device 330 is advanced downward or distally towards the distal end or outlet end 348 of the liner as shown in FIG. 35. The tissue acquisition and fixation device is then actuated to place dual or single fold plications 350 along the lesser curve LC of the stomach until the liner is sufficiently anchored to the stomach wall. In other embodiments, the cylindrical body 344 of the liner may extend to the pylorus, and longitudinal plications would be placed all the way down the lesser curve to the pylorus, securing the liner with the dual or single folds of tissue. FIG. 36 shows a cross-sectional view taken along line 36-36 of FIG. 35, showing multiple plications 350 securing the liner 343 within dual folds DF of the stomach wall SW near the GEJ. Referring to FIG. 37, a cross-sectional view taken along line 37-37 of FIG. 35, showing a longitudinal plication 350 securing the liner to the lesser curve of the stomach.


Although the present invention has been described in terms of certain preferred embodiments, other embodiments that are apparent to those of ordinary skill in the art are also within the scope of the invention. Accordingly, the scope of the invention is intended to be defined only by reference to the appended claims. While the dimensions, types of materials described herein are intended to define the parameters of the invention, they are by no means limiting and are exemplary embodiments.

Claims
  • 1. A method for treatment of a stomach cavity, comprising: positioning a tubular liner having a central lumen and proximal and distal ends within the stomach cavity such that the proximal end is adjacent the gastroesophageal junction;acquiring first and second folds of tissue and the liner using a fixation device, and plicating the first fold of tissue, the second fold of tissue, and the liner to fix the proximal end of said tubular liner to the stomach wall adjacent the gastroesophageal junction; andacquiring third and fourth folds of tissue and the liner using the fixation device, and plicating the third fold of tissue, the fourth fold of tissue, and the liner to fix the distal end of said tubular liner to the stomach wall adjacent the pylorus.
  • 2. The method of claim 1, further comprising fixing at least a portion of the tubular liner within a dual fold of tissue along the lesser curve of the stomach cavity.
  • 3. The method of claim 1, further comprising fixing the tubular liner within folds of tissue a plurality of times along the lesser curve of the stomach cavity.
  • 4. The method of claim 1, wherein the tubular liner includes a cylindrical body with a central lumen in communication with an inlet end and an outlet end, the inlet end being in communication with the esophagus, and further comprising fixing at least a portion of the cylindrical body of the tubular liner within a fold of tissue along the lesser curve of the stomach cavity.
  • 5. The method of claim 4, further comprising attaching a first valve near the inlet end of the tubular liner and attaching a second valve near the outlet end of the tubular liner.
  • 6. The method of claim 1, further comprising fixing a plurality of points around a circumference of the tubular liner between dual folds of tissue in the stomach cavity.
  • 7. The method of claim 1, wherein plicating the proximal and distal_ends of the tubular liner is achieved with staples, sutures, rivets, grommets or adhesive.
  • 8. The method of claim 1, the tubular liner includes a spine with a first end and a second end and a first valve attached to the first end of the spine, and further comprising fixing at least a portion of the spine within a fold of tissue along the lesser curve of the stomach cavity.
  • 9. The method of claim 8, wherein, the tubular liner includes a second valve attached to the second end of the spine, the first valve being positioned near the gastroesophageal junction and the second valve being positioned near the pyloric valve.
  • 10. The method of claim 1, further comprising using a sheath to hold the tubular liner.
  • 11. The method of claim 1, further comprising selecting a tubular liner manufactured from at least one of a group comprising PET, Nylon, polyester, PTFE, polyethylene, polystyrene, polyurethane, silicone, and polyethylene terephthalate.
CROSS-REFERENCE TO RELATED APPLICATION

This application is claiming priority to the following provisional applications: U.S. Ser. No. 60/556,489 filed Mar. 26, 2004; and U.S. Ser. No. 60/569,037 filed May 10, 2004, the entire contents of each are incorporated herein by reference.

US Referenced Citations (390)
Number Name Date Kind
2108206 Meeker Feb 1938 A
2508690 Schmerl May 1950 A
3372443 Daddona, Jr. Mar 1968 A
3395710 Stratton et al. Aug 1968 A
3986493 Hendren, III Oct 1976 A
4057065 Thow Nov 1977 A
4063561 McKenna Dec 1977 A
4133315 Berman et al. Jan 1979 A
4134405 Smit Jan 1979 A
4198982 Fortner et al. Apr 1980 A
4246893 Berson Jan 1981 A
4258705 Sorensen et al. Mar 1981 A
4311146 Wonder Jan 1982 A
4315509 Smit Feb 1982 A
4343066 Lance Aug 1982 A
4402445 Green Sep 1983 A
4416267 Garren et al. Nov 1983 A
4458681 Hopkins Jul 1984 A
4485805 Foster, Jr. Dec 1984 A
4501264 Rockey Feb 1985 A
4547192 Brodsky et al. Oct 1985 A
4558699 Bashour Dec 1985 A
4592339 Kuzmak et al. Jun 1986 A
4592354 Rothfuss Jun 1986 A
4598699 Garren et al. Jul 1986 A
4607618 Angelchik Aug 1986 A
4610383 Rothfuss et al. Sep 1986 A
4636205 Steer Jan 1987 A
4641653 Rockey Feb 1987 A
4643169 Koss et al. Feb 1987 A
4646722 Silverstein et al. Mar 1987 A
4648383 Angelchik Mar 1987 A
4671287 Fiddian-Green Jun 1987 A
4694827 Weiner et al. Sep 1987 A
4716900 Ravo et al. Jan 1988 A
4723547 Kullas et al. Feb 1988 A
4739758 Lai et al. Apr 1988 A
4744363 Hasson May 1988 A
4773393 Haber et al. Sep 1988 A
4790294 Allred, III et al. Dec 1988 A
4795430 Quinn et al. Jan 1989 A
4803985 Hill Feb 1989 A
4841888 Mills et al. Jun 1989 A
4899747 Garren et al. Feb 1990 A
4905693 Ravo Mar 1990 A
4925446 Garay et al. May 1990 A
4927428 Richards May 1990 A
4969474 Schwarz Nov 1990 A
5037021 Mills et al. Aug 1991 A
5059193 Kuslich Oct 1991 A
5080663 Mills et al. Jan 1992 A
5084061 Gau et al. Jan 1992 A
5112310 Grobe May 1992 A
5129915 Cantenys Jul 1992 A
5156609 Nakao et al. Oct 1992 A
5171233 Amplatz et al. Dec 1992 A
5197649 Bessler et al. Mar 1993 A
5220928 Oddsen et al. Jun 1993 A
5222961 Nakao et al. Jun 1993 A
5226429 Kuzmak Jul 1993 A
5234454 Bangs Aug 1993 A
5246456 Wilkinson Sep 1993 A
5248302 Patrick et al. Sep 1993 A
5250058 Miller et al. Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5259366 Reydel et al. Nov 1993 A
5259399 Brown Nov 1993 A
5261920 Main et al. Nov 1993 A
5263629 Trumbull et al. Nov 1993 A
5297536 Wilk Mar 1994 A
5301658 Zhu et al. Apr 1994 A
5306300 Berry Apr 1994 A
5309896 Moll et al. May 1994 A
5309927 Welch May 1994 A
5327914 Shlain Jul 1994 A
5330486 Wilk Jul 1994 A
5330503 Yoon Jul 1994 A
5331975 Bonutti Jul 1994 A
5334209 Yoon Aug 1994 A
5334210 Gianturco Aug 1994 A
5345949 Shlain Sep 1994 A
5346501 Regula et al. Sep 1994 A
5355897 Pietrafitta et al. Oct 1994 A
5376095 Ortiz Dec 1994 A
5382231 Shlain Jan 1995 A
5403312 Yates et al. Apr 1995 A
5403326 Harrison et al. Apr 1995 A
5411508 Bessler et al. May 1995 A
5433721 Hooven et al. Jul 1995 A
5437291 Pasricha et al. Aug 1995 A
5449368 Kuzmak Sep 1995 A
5452837 Williamson, IV et al. Sep 1995 A
5458131 Wilk Oct 1995 A
5465894 Clark et al. Nov 1995 A
5467911 Tsuruta et al. Nov 1995 A
5486183 Middleman et al. Jan 1996 A
5489058 Plyley et al. Feb 1996 A
5503635 Sauer et al. Apr 1996 A
5527319 Green et al. Jun 1996 A
5535935 Vidal et al. Jul 1996 A
5542949 Yoon Aug 1996 A
5549621 Bessler et al. Aug 1996 A
5551622 Yoon Sep 1996 A
5555898 Suzuki et al. Sep 1996 A
5558665 Kieturakis Sep 1996 A
5571116 Bolanos et al. Nov 1996 A
5577654 Bishop Nov 1996 A
5578044 Gordon et al. Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5584861 Swain et al. Dec 1996 A
5588579 Schnut et al. Dec 1996 A
5601604 Vincent Feb 1997 A
5603443 Clark et al. Feb 1997 A
5607094 Clark et al. Mar 1997 A
5624381 Kieturakis Apr 1997 A
5626588 Sauer et al. May 1997 A
5639008 Gallagher et al. Jun 1997 A
5649937 Bito et al. Jul 1997 A
5651769 Waxman et al. Jul 1997 A
5655698 Yoon Aug 1997 A
5662664 Gordon et al. Sep 1997 A
5662667 Knodel Sep 1997 A
5667520 Bonutti Sep 1997 A
5676659 McGurk Oct 1997 A
5676674 Bolanos et al. Oct 1997 A
5685868 Lundquist Nov 1997 A
5690656 Cope et al. Nov 1997 A
5697943 Sauer et al. Dec 1997 A
5707382 Sierocuk et al. Jan 1998 A
5722990 Sugarbaker et al. Mar 1998 A
5728178 Buffington et al. Mar 1998 A
5735848 Yates et al. Apr 1998 A
5749893 Vidal et al. May 1998 A
5755730 Swain et al. May 1998 A
5766216 Gangal et al. Jun 1998 A
5776054 Bobra Jul 1998 A
5782844 Yoon et al. Jul 1998 A
5788715 Watson, Jr. et al. Aug 1998 A
5792153 Swain et al. Aug 1998 A
5797931 Bito et al. Aug 1998 A
5810851 Yoon Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5810882 Bolduc et al. Sep 1998 A
5816471 Plyley et al. Oct 1998 A
5820584 Crabb Oct 1998 A
5824008 Bolduc et al. Oct 1998 A
5827298 Hart et al. Oct 1998 A
5833690 Yates et al. Nov 1998 A
5836311 Borst et al. Nov 1998 A
5839639 Sauer et al. Nov 1998 A
5860581 Robertson et al. Jan 1999 A
5861036 Godin Jan 1999 A
5868141 Ellias Feb 1999 A
5868760 McGuckin, Jr. Feb 1999 A
5876448 Thompson et al. Mar 1999 A
5879371 Gardiner et al. Mar 1999 A
5887594 LoCicero, III Mar 1999 A
5888196 Bonutti Mar 1999 A
5897534 Heim et al. Apr 1999 A
5897562 Bolanos et al. Apr 1999 A
5904147 Conlan et al. May 1999 A
5906625 Bito et al. May 1999 A
5910105 Swain et al. Jun 1999 A
5910149 Kuzmak Jun 1999 A
5921993 Yoon Jul 1999 A
5927284 Borst et al. Jul 1999 A
5928264 Sugarbaker et al. Jul 1999 A
5935107 Taylor et al. Aug 1999 A
5938669 Klaiber et al. Aug 1999 A
5947983 Solar et al. Sep 1999 A
5964772 Bolduc et al. Oct 1999 A
5964782 Lafontaine et al. Oct 1999 A
5972001 Yoon Oct 1999 A
5972002 Bark et al. Oct 1999 A
5976161 Kirsch et al. Nov 1999 A
5980537 Ouchi Nov 1999 A
5993464 Knodel Nov 1999 A
5993473 Chan et al. Nov 1999 A
6015378 Borst et al. Jan 2000 A
6030364 Durgin et al. Feb 2000 A
6030392 Dakov Feb 2000 A
6042538 Puskas Mar 2000 A
6044847 Carter et al. Apr 2000 A
6067991 Forsell May 2000 A
6074343 Nathanson et al. Jun 2000 A
6083241 Longo et al. Jul 2000 A
6086600 Kortenbach Jul 2000 A
6113609 Adams Sep 2000 A
6119913 Adams et al. Sep 2000 A
6120513 Bailey et al. Sep 2000 A
6136006 Johnson et al. Oct 2000 A
6159146 El Gazayerli Dec 2000 A
6159195 Ha et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6179195 Adams et al. Jan 2001 B1
6186942 Sullivan et al. Feb 2001 B1
6186985 Snow Feb 2001 B1
6197022 Baker Mar 2001 B1
6200318 Har-Shai et al. Mar 2001 B1
6206822 Foley et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6224614 Yoon May 2001 B1
6231561 Frazier et al. May 2001 B1
6248058 Silverman et al. Jun 2001 B1
6254642 Taylor Jul 2001 B1
6273897 Dalessandro et al. Aug 2001 B1
6279809 Nicolo Aug 2001 B1
6290674 Roue et al. Sep 2001 B1
6293923 Yachia et al. Sep 2001 B1
6302917 Dua et al. Oct 2001 B1
6312437 Kortenbach Nov 2001 B1
6328689 Gonzalez et al. Dec 2001 B1
6338345 Johnson et al. Jan 2002 B1
6352543 Cole Mar 2002 B1
6358197 Silverman et al. Mar 2002 B1
6379366 Fleischman et al. Apr 2002 B1
6387104 Pugsley, Jr. et al. May 2002 B1
6398795 McAlister et al. Jun 2002 B1
6416535 Lazarus Jul 2002 B1
6423087 Sawada Jul 2002 B1
6432040 Meah Aug 2002 B1
6447533 Adams Sep 2002 B1
6460543 Forsell Oct 2002 B1
6475136 Forsell Nov 2002 B1
6491707 Makower et al. Dec 2002 B2
6494888 Laufer et al. Dec 2002 B1
6506196 Laufer Jan 2003 B1
6535764 Imran et al. Mar 2003 B2
6540789 Silverman et al. Apr 2003 B1
6551310 Ganz et al. Apr 2003 B1
6554844 Lee et al. Apr 2003 B2
6558400 Deem et al. May 2003 B2
6561969 Frazier et al. May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6592596 Geitz Jul 2003 B1
6605037 Moll et al. Aug 2003 B1
6626899 Houser et al. Sep 2003 B2
6632227 Adams Oct 2003 B2
6663598 Carrillo, Jr. et al. Dec 2003 B1
6663639 Laufer et al. Dec 2003 B1
6663640 Kortenbach Dec 2003 B2
6675809 Stack et al. Jan 2004 B2
6682520 Ingenito Jan 2004 B2
6689062 Mesallum Feb 2004 B1
6692485 Brock et al. Feb 2004 B1
6716222 McAlister et al. Apr 2004 B2
6733512 McGhan May 2004 B2
6736822 McClellan et al. May 2004 B2
6740098 Abrams et al. May 2004 B2
6740121 Geitz May 2004 B2
6746489 Dua et al. Jun 2004 B2
6754536 Swoyer et al. Jun 2004 B2
6755849 Gowda et al. Jun 2004 B1
6755869 Geitz Jun 2004 B2
6756364 Barbier et al. Jun 2004 B2
6764518 Godin Jul 2004 B2
6773440 Gannoe et al. Aug 2004 B2
6773441 Laufer et al. Aug 2004 B1
6786898 Guenst Sep 2004 B2
6790214 Kraemer et al. Sep 2004 B2
6802868 Silverman et al. Oct 2004 B2
6821285 Laufer et al. Nov 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6835200 Laufer et al. Dec 2004 B2
6837848 Bonner et al. Jan 2005 B2
6840423 Adams et al. Jan 2005 B2
6845776 Stack et al. Jan 2005 B2
6896682 McClellan et al. May 2005 B1
6926722 Geitz Aug 2005 B2
6966919 Sixto, Jr. et al. Nov 2005 B2
6981978 Gannoe Jan 2006 B2
6991643 Saadat Jan 2006 B2
7020531 Colliou et al. Mar 2006 B1
7025791 Levine et al. Apr 2006 B2
7033378 Smith et al. Apr 2006 B2
7037343 Imran May 2006 B2
7037344 Kagan et al. May 2006 B2
7063715 Onuki et al. Jun 2006 B2
7083630 DeVries et al. Aug 2006 B2
7087011 Cabiri et al. Aug 2006 B2
7097650 Weller et al. Aug 2006 B2
7520884 Swanstrom et al. Apr 2009 B2
20010014800 Frazier et al. Aug 2001 A1
20010020190 Taylor Sep 2001 A1
20010037127 De Hoyos Garza Nov 2001 A1
20020022851 Kalloo et al. Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020040226 Laufer et al. Apr 2002 A1
20020047036 Sullivan et al. Apr 2002 A1
20020058967 Jervis May 2002 A1
20020072761 Abrams et al. Jun 2002 A1
20020077661 Saadat Jun 2002 A1
20020078967 Sixto, Jr. et al. Jun 2002 A1
20020082621 Schurr et al. Jun 2002 A1
20020143346 McGuckin, Jr. et al. Oct 2002 A1
20020165589 Imran et al. Nov 2002 A1
20020183768 Deem et al. Dec 2002 A1
20020193816 Laufer et al. Dec 2002 A1
20030040804 Stack et al. Feb 2003 A1
20030040808 Stack et al. Feb 2003 A1
20030065340 Geitz Apr 2003 A1
20030065359 Weller et al. Apr 2003 A1
20030093117 Saadat May 2003 A1
20030109892 Deem et al. Jun 2003 A1
20030109931 Geitz Jun 2003 A1
20030109935 Geitz Jun 2003 A1
20030120265 Deem et al. Jun 2003 A1
20030120285 Kortenbach Jun 2003 A1
20030120289 McGuckin, Jr. et al. Jun 2003 A1
20030132267 Adams et al. Jul 2003 A1
20030158563 McClellan et al. Aug 2003 A1
20030158601 Silverman et al. Aug 2003 A1
20030171760 Gambale Sep 2003 A1
20030208209 Gambale et al. Nov 2003 A1
20030225312 Suzuki et al. Dec 2003 A1
20040006351 Gannoe et al. Jan 2004 A1
20040009224 Miller Jan 2004 A1
20040010271 Kortenbach Jan 2004 A1
20040024386 Deem et al. Feb 2004 A1
20040030347 Gannoe et al. Feb 2004 A1
20040034371 Lehman et al. Feb 2004 A1
20040037865 Miller Feb 2004 A1
20040039452 Bessler Feb 2004 A1
20040049209 Benchetrit Mar 2004 A1
20040059349 Sixto, Jr. et al. Mar 2004 A1
20040059354 Smith et al. Mar 2004 A1
20040059358 Kortenbach et al. Mar 2004 A1
20040082963 Gannoe et al. Apr 2004 A1
20040087977 Nolan et al. May 2004 A1
20040089313 Utley et al. May 2004 A1
20040092892 Kagan et al. May 2004 A1
20040092974 Gannoe et al. May 2004 A1
20040097989 Trigueros May 2004 A1
20040107004 Levine et al. Jun 2004 A1
20040116949 Ewers et al. Jun 2004 A1
20040122456 Saadat et al. Jun 2004 A1
20040122473 Ewers et al. Jun 2004 A1
20040122526 Imran Jun 2004 A1
20040133147 Woo Jul 2004 A1
20040133238 Cerier Jul 2004 A1
20040138525 Saadat Jul 2004 A1
20040138526 Guenst Jul 2004 A1
20040138529 Wiltshire et al. Jul 2004 A1
20040138531 Bonner et al. Jul 2004 A1
20040138682 Onuki et al. Jul 2004 A1
20040147958 Lam et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040148034 Kagan et al. Jul 2004 A1
20040158331 Stack et al. Aug 2004 A1
20040162568 Saadat et al. Aug 2004 A1
20040167546 Saadat et al. Aug 2004 A1
20040172141 Stack et al. Sep 2004 A1
20040181242 Stack et al. Sep 2004 A1
20040193190 Liddicoat et al. Sep 2004 A1
20040210243 Gannoe et al. Oct 2004 A1
20040225183 Michlitsch et al. Nov 2004 A1
20040225194 Smith et al. Nov 2004 A1
20040225305 Ewers et al. Nov 2004 A1
20050021681 Oommen Jan 2005 A1
20050038415 Rohr et al. Feb 2005 A1
20050049718 Dann et al. Mar 2005 A1
20050055038 Kelleher et al. Mar 2005 A1
20050055039 Burnett et al. Mar 2005 A1
20050075622 Levine et al. Apr 2005 A1
20050075653 Saadat et al. Apr 2005 A1
20050080444 Kraemer et al. Apr 2005 A1
20050085787 Laufer Apr 2005 A1
20050096750 Kagan et al. May 2005 A1
20050119671 Reydel et al. Jun 2005 A1
20050143760 Imran Jun 2005 A1
20050148818 Mesallum Jul 2005 A1
20050149067 Takemoto et al. Jul 2005 A1
20050149114 Cartledge et al. Jul 2005 A1
20050194038 Brabec et al. Sep 2005 A1
20050194294 Oexle et al. Sep 2005 A1
20050194312 Niemeyer et al. Sep 2005 A1
20050195925 Traber Sep 2005 A1
20050195944 Bartels et al. Sep 2005 A1
20050196356 Leinen et al. Sep 2005 A1
20050197540 Liedtke Sep 2005 A1
20050197622 Blumenthal et al. Sep 2005 A1
20050197684 Koch Sep 2005 A1
20050198476 Gazsi et al. Sep 2005 A1
20050228415 Gertner Oct 2005 A1
20050247320 Stack et al. Nov 2005 A1
20050256587 Egan Nov 2005 A1
20060020247 Kagan et al. Jan 2006 A1
20060020254 Hoffmann Jan 2006 A1
20060020276 Saadat et al. Jan 2006 A1
20060036267 Saadat et al. Feb 2006 A1
Foreign Referenced Citations (50)
Number Date Country
0 137 878 Apr 1985 EP
0 174 843 Mar 1986 EP
0 246 999 Nov 1987 EP
0 540 010 May 1993 EP
63277063 Nov 1988 JP
63279854 Nov 1988 JP
63302863 Dec 1988 JP
1049572 Feb 1989 JP
4297219 Oct 1992 JP
WO 9418893 Sep 1994 WO
WO 9917662 Apr 1999 WO
WO 9953827 Oct 1999 WO
WO 0032137 Jun 2000 WO
WO 0048656 Aug 2000 WO
WO 0078227 Dec 2000 WO
WO 0078229 Dec 2000 WO
WO 0166018 Sep 2001 WO
WO 0167964 Sep 2001 WO
WO 0185034 Nov 2001 WO
WO 0224080 Mar 2002 WO
WO 0235980 May 2002 WO
WO 0239880 May 2002 WO
WO 02071951 Sep 2002 WO
WO 02091961 Nov 2002 WO
WO 02096327 Dec 2002 WO
WO 03007796 Jan 2003 WO
WO 03017882 Mar 2003 WO
WO 03078721 Sep 2003 WO
WO 03086247 Oct 2003 WO
WO 03088844 Oct 2003 WO
WO 03094785 Nov 2003 WO
WO 03099140 Dec 2003 WO
WO 03105563 Dec 2003 WO
WO 03105671 Dec 2003 WO
WO 2004009269 Jan 2004 WO
WO 2004014237 Feb 2004 WO
WO 2004017863 Mar 2004 WO
WO 2004019787 Mar 2004 WO
WO 2004019826 Mar 2004 WO
WO 2004037064 May 2004 WO
WO 2004049911 Jun 2004 WO
WO 2004058102 Jul 2004 WO
WO 2004060150 Jul 2004 WO
WO 2004087014 Oct 2004 WO
WO 2004103189 Dec 2004 WO
WO 2005023118 Mar 2005 WO
WO 2005037152 Apr 2005 WO
WO 2005058239 Jun 2005 WO
WO 2005060882 Jul 2005 WO
WO 2006078781 Jul 2006 WO
Related Publications (1)
Number Date Country
20050228504 A1 Oct 2005 US
Provisional Applications (2)
Number Date Country
60556489 Mar 2004 US
60569037 May 2004 US